The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common cause of cancer related death in the world. Cisplatin and carboplatin are the most commonly used cytotoxic chemotherapeutic agents to treat the disease. These agents, usually combined with drugs such as gemcitabine or pemetrexed, induce objective...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Molecular Diversity Preservation International (MDPI)
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756421/ |